Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194285 · ClinicalTrials.gov registry record
FDG-PET Imaging in Painful Joint Prosthesis
A clinical trial of Painful Joint Prostheses, sponsored by University of Pennsylvania.
- Active
- Registry status
- 530
- Enrollment target
- 1
- Study location
NCT00194285: Active study of Painful Joint Prostheses, sponsored by University of Pennsylvania.
NCT00194285 is a study of Painful Joint Prostheses that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 530 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194285, a study of Painful Joint Prostheses, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 530 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of the proposed research study is to determine the efficacy of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiating infections from other complications such as loosening in patients with painful joint prosthesis. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities such as white blood imaging and patient outcome. We expect that at the completion of the proposed research, the role of this novel and powerful imaging modality will be clearly defined in the management of patients with this challenging and serious complication.
Primary Outcome
Standardized Uptake Value
Conditions Studied
Interventions
- PROCEDURE FDG-PET Imaging
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 2001-03 |
| Est. Completion | 2027-02 |
What the registry record for NCT00194285 still lists
NCT00194285 is an observational study that tracks outcomes without assigning an intervention. The registered 530 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Painful Joint Prostheses appearing as the primary indexed condition, and to 1 intervention - of which FDG-PET Imaging is the first listed.
NCT00194285 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00194285 about?
NCT00194285 is a clinical study titled "FDG-PET Imaging in Painful Joint Prosthesis". The main objective of the proposed research study is to determine the efficacy of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiating infections from other complications such as loosening in patients with painful joint prosthesis. We intend to validate and establi...
What is the current status of trial NCT00194285?
This trial is currently active not recruiting. The enrollment target is 530 participants. The study started on 2001-03. Estimated completion is 2027-02.
What conditions does trial NCT00194285 study?
This clinical trial studies the following conditions: Painful Joint Prostheses.
What interventions are being tested in trial NCT00194285?
The interventions under investigation include: FDG-PET Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00194285?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194285 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia